PILL
Direxion Daily Pharmaceutical & Medical Bull 3X ETF
1W: -1.7%
1M: -25.2%
3M: -20.6%
YTD: -15.0%
1Y: +45.8%
3Y: +20.1%
5Y: -60.7%
$10.00
-0.20 (-1.96%)
After Hours: $9.62 (-0.38, -3.75%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$19M
Holdings58
Top 10 Wt1094.7%
Beta2.11
% Profitable37%
Coverage68%
Portfolio Valuation
P/E24.9
P/B1.6
P/S5.4
EV/EBITDA17.4
P/FCF28.6
PEG1.58
Profitability & Returns
Gross Margin78.0%
Net Margin19.8%
ROE9.4%
ROA5.0%
ROIC7.2%
Div Yield0.77%
Leverage & Liquidity
Debt/Equity0.25
Debt/Assets0.15
Net Debt/EBITDA-0.3x
Interest Cov10.7x
Current Ratio1.70
Quick Ratio1.44
Growth (YoY)
Revenue+32.3%
Net Income+26.4%
EPS+32.6%
FCF+7.8%
EBITDA+31.6%
Rev CAGR 3Y+45.4%
Quality Scores
Piotroski F4.9
Altman Z9.06
IS Quality56.2
IS Overall47.6
IS Value43.4
Median P/E-4.5
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Other | 4 | 271.0% | — |
| Healthcare | 57 | 69.8% | 24.5 |
Smart Money Overlap
3 holdings with signals
Showing 50 of 61 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | S&P PHARMACEUTICALS SELECT INDEX SWAP Swap | 230.19% | $28.3M | 4,615 | — | — | — | |
| 2 | GOLDMAN FINL SQ TRSRY INST 506 Private | 25.31% | $3.1M | 3,116,847 | — | — | — | |
| 3 | DREYFUS GOVT CASH MAN INS Bond | 12.34% | $1.5M | 1,519,381 | — | — | — | |
| 4 | GOLDMAN SACHS FIN GOV 465 INSTITUT Private | 3.17% | $390,000 | 390,000 | — | — | — | |
| 5 | Definium Therapeutics, Inc | DFTX | 2.08% | $256,462 | 13,999 | — | $1.9B | Healthcare |
| 6 | EDGEWISE THERAPEUTICS INC | EWTX | 1.77% | $217,394 | 7,300 | -19.4 | $3.4B | Healthcare |
| 7 | NEKTAR THERAPEUTICS | NKTR | 1.76% | $216,702 | 3,001 | -8.8 | $1.4B | Healthcare |
| 8 | ROYALTY PHARMA PLC- CL A | RPRX | 1.70% | $208,787 | 4,529 | 26.3 | $20.1B | Healthcare |
| 9 | PHIBRO ANIMAL HEALTH CORP-A | PAHC | 1.67% | $206,266 | 4,031 | 24.6 | $2.3B | Healthcare |
| 10 | MERCK & CO. INC. | MRK | 1.67% | $205,119 | 1,777 | 16.2 | $294.1B | Healthcare |
| 11 | JOHNSON & JOHNSON | JNJ | 1.66% | $204,036 | 839 | 21.7 | $576.5B | Healthcare |
| 12 | BRISTOL-MYERS SQUIBB CO | BMY | 1.64% | $202,118 | 3,385 | 17.2 | $121.0B | Healthcare |
| 13 | VIATRIS INC | VTRS | 1.64% | $201,853 | 14,941 | -4.4 | $15.4B | Healthcare |
| 14 | MAZE THERAPEUTICS INC | MAZE | 1.62% | $199,299 | 3,888 | -10.4 | $1.5B | Healthcare |
| 15 | LIGAND PHARMACEUTICALS | LGND | 1.59% | $195,748 | 942 | 32.3 | $4.1B | Healthcare |
| 16 | JAZZ PHARMACEUTICALS PLC | JAZZ | 1.55% | $191,121 | 1,050 | -32.4 | $11.6B | Healthcare |
| 17 | ELANCO ANIMAL HEALTH INC | ELAN | 1.55% | $190,406 | 8,137 | -52.6 | $12.2B | Healthcare |
| 18 | LIQUIDIA CORP | LQDA | 1.54% | $189,317 | 5,303 | -46.5 | $3.2B | Healthcare |
| 19 | SUPERNUS PHARMACEUTICALS INC | SUPN | 1.53% | $188,488 | 3,754 | -75.6 | $2.9B | Healthcare |
| 20 | AMYLYX PHARMACEUTICALS INC | AMLX | 1.53% | $188,392 | 13,101 | -8.8 | $1.1B | Healthcare |
| 21 | INNOVIVA INC | INVA | 1.51% | $186,193 | 8,406 | 6.3 | $1.5B | Healthcare |
| 22 | AXSOME THERAPEUTICS INC | AXSM | 1.49% | $183,863 | 1,162 | -45.4 | $8.4B | Healthcare |
| 23 | MBX BIOSCIENCES INC | MBX | 1.46% | $179,247 | 6,015 | -11.9 | $950M | Healthcare |
| 24 | ENLIVEN THERAPEUTICS INC | ELVN | 1.45% | $179,048 | 6,537 | -21.5 | $2.3B | Healthcare |
| 25 | TERNS PHARMACEUTICALS INC | TERN | 1.45% | $179,028 | 3,886 | -51.6 | $4.8B | Healthcare |
| 26 | PFIZER INC | PFE | 1.45% | $178,899 | 6,723 | 20.2 | $156.7B | Healthcare |
| 27 | ZOETIS INC | ZTS | 1.41% | $173,326 | 1,467 | 19.1 | $51.4B | Healthcare |
| 28 | ELI LILLY & CO | LLY | 1.40% | $172,107 | 174 | 39.0 | $847.1B | Healthcare |
| 29 | PRESTIGE CONSUMER HEALTHCARE | PBH | 1.40% | $172,010 | 2,824 | 15.5 | $2.9B | Healthcare |
| 30 | AMNEAL PHARMACEUTICALS INC | AMRX | 1.38% | $169,488 | 14,195 | 52.4 | $3.8B | Healthcare |
| 31 | ARVINAS INC | ARVN | 1.30% | $160,684 | 13,085 | -8.7 | $698M | Healthcare |
| 32 | RAPPORT THERAPEUTICS INC | RAPP | 1.30% | $159,671 | 5,781 | -12.2 | $1.1B | Healthcare |
| 33 | PACIRA BIOSCIENCES INC | PCRX | 1.27% | $156,175 | 6,883 | 140.8 | $1.0B | Healthcare |
| 34 | ORGANON & CO | OGN | 1.24% | $153,035 | 24,138 | 8.4 | $1.6B | Healthcare |
| 35 | ANI PHARMACEUTICALS INC | ANIP | 1.24% | $152,495 | 2,113 | 19.6 | $1.7B | Healthcare |
| 36 | INDIVIOR PHARMACEUTICALS INC | INDV | 1.23% | $151,443 | 4,890 | 17.8 | $3.7B | Healthcare |
| 37 | TARSUS PHARMACEUTICALS INC | TARS | 1.19% | $146,895 | 2,132 | -43.3 | $2.9B | Healthcare |
| 38 | EYEPOINT INC | EYPT | 1.13% | $139,409 | 10,365 | -4.7 | $1.1B | Healthcare |
| 39 | XERIS BIOPHARMA HOLDINGS INC | XERS | 1.11% | $137,107 | 24,974 | 1668.6 | $960M | Healthcare |
| 40 | TREVI THERAPEUTICS INC | TRVI | 1.11% | $136,487 | 12,230 | -40.2 | $1.5B | Healthcare |
| 41 | CRINETICS PHARMACEUTICALS IN | CRNX | 1.09% | $134,394 | 3,605 | -7.3 | $3.8B | Healthcare |
| 42 | COLLEGIUM PHARMACEUTICAL INC | COLL | 1.03% | $126,344 | 3,547 | 16.9 | $1.1B | Healthcare |
| 43 | PERRIGO CO PLC | PRGO | 1.01% | $124,610 | 12,820 | -0.9 | $1.3B | Healthcare |
| 44 | HARMONY BIOSCIENCES HOLDINGS | HRMY | 1.00% | $122,946 | 4,413 | 10.0 | $1.6B | Healthcare |
| 45 | ESPERION THERAPEUTICS INC | ESPR | 0.99% | $121,731 | 45,253 | -29.7 | $593M | Healthcare |
| 46 | HARROW INC | HROW | 0.98% | $120,509 | 3,452 | -253.1 | $1.3B | Healthcare |
| 47 | ZEVRA THERAPEUTICS INC | ZVRA | 0.95% | $116,486 | 11,802 | 6.2 | $552M | Healthcare |
| 48 | AMPHASTAR PHARMACEUTICALS IN | AMPH | 0.90% | $110,540 | 5,695 | 9.1 | $897M | Healthcare |
| 49 | PHATHOM PHARMACEUTICALS INC | PHAT | 0.87% | $107,229 | 10,271 | -3.6 | $850M | Healthcare |
| 50 | WAVE LIFE SCIENCES LTD | WVE | 0.86% | $106,304 | 8,566 | -5.5 | $1.2B | Healthcare |